Segall Bryant & Hamill’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-61,422
| Closed | -$5.62M | – | 518 |
|
|
2023
Q2 | $5.62M | Sell |
61,422
-65,981
| -52% | -$6.03M | 0.06% | 320 |
|
|
2023
Q1 | $9.37M | Buy |
127,403
+2,055
| +2% | +$151K | 0.1% | 236 |
|
|
2022
Q4 | $10.5M | Sell |
125,348
-39,885
| -24% | -$3.33M | 0.12% | 213 |
|
|
2022
Q3 | $16M | Buy |
165,233
+12,082
| +8% | +$1.17M | 0.19% | 145 |
|
|
2022
Q2 | $16.1M | Buy |
153,151
+26,253
| +21% | +$2.76M | 0.18% | 149 |
|
|
2022
Q1 | $21.9M | Buy |
126,898
+13,810
| +12% | +$2.38M | 0.21% | 129 |
|
|
2021
Q4 | $18.3M | Buy |
113,088
+894
| +0.8% | +$145K | 0.17% | 149 |
|
|
2021
Q3 | $16.7M | Buy |
112,194
+19,826
| +21% | +$2.96M | 0.16% | 154 |
|
|
2021
Q2 | $22.6M | Buy |
92,368
+9,698
| +12% | +$2.38M | 0.22% | 123 |
|
|
2021
Q1 | $21.9M | Sell |
82,670
-2,913
| -3% | -$771K | 0.22% | 129 |
|
|
2020
Q4 | $25.1M | Buy |
85,583
+2,013
| +2% | +$590K | 0.28% | 99 |
|
|
2020
Q3 | $19.8M | Buy |
83,570
+38,204
| +84% | +$9.03M | 0.27% | 96 |
|
|
2020
Q2 | $9.01M | Buy |
45,366
+13,261
| +41% | +$2.63M | 0.15% | 145 |
|
|
2020
Q1 | $5.89M | Buy |
32,105
+20,015
| +166% | +$3.67M | 0.12% | 168 |
|
|
2019
Q4 | $2.02M | Sell |
12,090
-1,118
| -8% | -$187K | 0.03% | 392 |
|
|
2019
Q3 | $1.73M | Buy |
13,208
+1,116
| +9% | +$146K | 0.03% | 431 |
|
|
2019
Q2 | $1.47M | Buy |
12,092
+51
| +0.4% | +$6.19K | 0.02% | 457 |
|
|
2019
Q1 | $1.49M | Buy |
12,041
+293
| +2% | +$36.1K | 0.02% | 465 |
|
|
2018
Q4 | $1.38M | Sell |
11,748
-454
| -4% | -$53.2K | 0.02% | 465 |
|
|
2018
Q3 | $1.53M | Sell |
12,202
-10,518
| -46% | -$1.31M | 0.02% | 481 |
|
|
2018
Q2 | $1.94M | Buy |
+22,720
| New | +$1.94M | 0.03% | 436 |
|